Tested Applications
Positive WB detected in | HeLa cells, HepG2 cells, U-251 cells, HT-29 cells |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
83342-1-RR targets RHOBTB1 in WB, ELISA applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | RHOBTB1 fusion protein Ag3365 Predict reactive species |
Full Name | Rho-related BTB domain containing 1 |
Calculated Molecular Weight | 696 aa, 79 kDa |
Observed Molecular Weight | 79 kDa |
GenBank Accession Number | BC032848 |
Gene Symbol | RHOBTB1 |
Gene ID (NCBI) | 9886 |
RRID | AB_3671003 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | O94844 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Rho-related BTB domain containing protein 1 (RhoBTB1) is also named as KIAA0740. RhoBTB1 is an atypical Rho GTPase with two BTB domains in addition to its Rho domain. RhoBTB1 is a substrate for ROCK1, and mutation of putative phosphorylation sites reduces its association with Cullin3, a scaffold for ubiquitin ligases (PMID: 31431478). RHOBTB1 is a novel PPARγ gene target in vascular smooth muscle cells that mediates the protective effect of PPARγ by serving as a substrate adaptor between the Cullin-3 RING ubiquitin ligase and phosphodiesterase 5, thus restraining its activity through ubiquitination and proteasomal degradation (PMID: 31789920).
Protocols
Product Specific Protocols | |
---|---|
WB protocol for RHOBTB1 antibody 83342-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |